Реакция #157984

ord-33004f25daeb4eaa95b6c15a34f6c655

Растворители

Условия реакции

Подробные условия
See reaction.notes.procedure_details.

Обработка

  1. 1
    ДругоеThe aqueous phase is removed
  2. 2
    Экстракцияextracted with ethyl acetate
  3. 3
    СушкаThe combined organic phases are dried over sodium sulfate
  4. 4
    ФильтрацияThe solids are filtered off
  5. 5
    workup.DISTILLATIONthe solvent is distilled off
  6. 6
    ДругоеThe residue is purified by chromatography

Методика

To a solution of 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid (E, 160 mg) in dichloromethane (5 ml) are added, at room temperature, 2-chlorocyclohexanol (57 mg), 4-dimethylaminopyridine (4 mg) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (94 mg). The mixture is stirred overnight, and water is then added. The aqueous phase is removed and extracted with ethyl acetate. The combined organic phases are dried over sodium sulfate. The solids are filtered off and the solvent is distilled off. The residue is purified by chromatography. This gives 2-chlorocyclohexyl 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylate (100 mg, 50%).

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US08822693B2uspto-grants-2014_09